Core Laboratories
CLB
174 hedge funds and large institutions have $956M invested in Core Laboratories in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 67 reducing their positions, and 41 closing their positions.
75% more call options, than puts
Call options by funds: $2.28M | Put options by funds: $1.3M
0.04% more ownership
Funds ownership: 92.51% → 92.56% (+0.04%)
12% less funds holding
Funds holding: 198 → 174 (-24)
18% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 67
19% less capital invested
Capital invested by funds: $1.19B → $956M (-$231M)
54% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 41
Top Buyers
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$92.4M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$17.3M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$9.5M |
| 4 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$8.45M |
| 5 |
CPH
C Partners Holding
Zurich,
Switzerland
|
+$8.14M |
Top Sellers
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$52.9M |
| 2 |
ClearBridge Investments
New York
|
-$43.9M |
| 3 |
FAM
Fred Alger Management
New York
|
-$29.2M |
| 4 |
VanEck Associates
New York
|
-$8.74M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$4.88M |
CLB Hedge Fund Activity: Q4 2021 in Review
174 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2021, worth a combined $956M — down 19% from $1.19B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of CLB and 19 opened new positions — a net loss of 22 holders — while 67 trimmed existing stakes and 55 added.
The largest buyer was Ariel Investments, adding an estimated $92.4M. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $52.9M sold.
- 174 institutional investors held Core Laboratories (CLB) as of Q4 2021, down from 198 in Q3 2021.
- Funds reported $956M of Core Laboratories stock for Q4 2021, down 19% quarter-over-quarter.
- 19 funds opened new Core Laboratories positions in Q4 2021 and 41 closed out, a net change of -22 holders.
- The largest Core Laboratories buyer in Q4 2021 was Ariel Investments, an estimated $92.4M added.
- The largest Core Laboratories seller in Q4 2021 was Massachusetts Financial Services, an estimated $52.9M sold.
Based on aggregated 13F filings for Q4 2021.